search
Back to results

Evaluation of the Performance of an e-Health System

Primary Purpose

Chronic Diseases

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
medical device intervention
Sponsored by
Air Liquide Santé International
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Chronic Diseases focused on measuring chronic heart failure, chronic obstructive pulmonary disease, diabetes

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Patients presenting all the following characteristics are eligible for inclusion:

  1. Adult (>18 yrs), male or female
  2. Presenting at least two chronic diseases among the following three: chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes
  3. Having been hospitalized in the CHANGE or in any other medical care center (hospital or private clinic) for acute decompensation of CHF or exacerbation of COPD at least once during the 12 months prior to inclusion
  4. Able to speak and understand French to a satisfactory standard
  5. Having a phone land line
  6. Capable of understanding and accepting the study constraints
  7. Having signed a written informed consent after a full explanation of the study by the investigator prior to inclusion

Exclusion Criteria:

Patients presenting any one of the following characteristics are not eligible for inclusion:

  1. Pregnant or breast-feeding woman
  2. Institutionalized
  3. Having a life expectancy of less than 3 months
  4. Receiving or having received chemotherapy or radiotherapy for cancer within the past 6 months
  5. Undergoing dialysis for chronic renal insufficiency
  6. Presenting a condition likely to hamper accomplishment of the study procedures, such as chronic alcoholism, drug or solvent addiction, uncontrolled psychiatric disease or severe cognitive deficiency
  7. Not covered by French Social Security
  8. Participating or having participated in another interventional trial within the past 30 days

Sites / Locations

  • Cabinet Privé de Cardiologie - 2, rue jean jaurès
  • Cabinet Privé de Pneumologie - 7 rue gabriel de mortillet
  • Centre Hospitalier d'Annecy Genevois - service cardiologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy
  • Centre Hospitalier d'Annecy Genevois - service pneumologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy
  • Cabinet privé de pneumologie - 28 avenue de Genève
  • cabinet privé de médecine générale - 18, rue Louis Haase

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

medical device intervention

Arm Description

Outcomes

Primary Outcome Measures

Sensitivity and specificity of the tele-notifications

Secondary Outcome Measures

Sensitivity and specificity of the STABILITY SYSTEM INDICATORS
Specific self-administered questionnaires about Ease of Use/Usefulness/Satisfaction for each category of user
Acceptability of the system by patients regarding transmission of measured parameters
Mean number of transmission of measured parameters: real versus theoretical.
Acceptability of the system by patients: mean number of participation in virtual classroom session
Acceptability of the system by patients: mean duration of participation in virtual classroom session
Acceptability of the system by patients: mean number of consultations of modules providing medical information
Acceptability of the system by patients: cumulative time spent on consultations of modules providing medical information
Acceptability of the system by patients: mean duration of phone contacts by type (planned, for notification management, incoming)
Acceptability of the system by patients: mean number of phone contacts by type (planned, for notification management, incoming)
Acceptability of the system by patients: comparison of real planned phone contacts versus theoretical
Acceptability of the system by physicians: mean number of connections
Acceptability of the system by physicians: mean duration of connections
Feasibility of the intervention for patients
number of screening failure and prematurely withdrawal
Feasibility of the intervention for technicians
duration of intervention
Feasibility of the intervention for nurses
response time following a notification
Technological performance indices of the system: failures in data transmission
Technological performance indices of the system: inaccessibility
Technological performance indices of the system: devices deficiencies
technical problems with any medical devices (leading or not to replacement).
Number of tele-notification per patient
Frequency of tele-notifications per patient
Patient care plan: number of changes implemented by investigators.
Clinical events including medical consultations, hospitalizations and adverse events
Overall description of medical consultations, hospitalizations and adverse events. For adverse events, in addition, evaluation of seriousness and causal relationship with the medical device of the study.

Full Information

First Posted
May 23, 2016
Last Updated
May 11, 2017
Sponsor
Air Liquide Santé International
Collaborators
Inferential
search

1. Study Identification

Unique Protocol Identification Number
NCT02803489
Brief Title
Evaluation of the Performance of an e-Health System
Official Title
Evaluation of the Performance of an e-Health System Comprising Tele-monitoring / Tele-notification and Tele-coaching in Ambulatory Multi-morbid Adult Patients
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Terminated
Why Stopped
inclusion rate too low & investigators enable to recruit new patients rapidly
Study Start Date
April 8, 2016 (Actual)
Primary Completion Date
March 23, 2017 (Actual)
Study Completion Date
May 9, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Air Liquide Santé International
Collaborators
Inferential

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Prospective, non-randomized, open-label, pilot study conducted in a single group of 30 evaluable patients, i.e. patients completing an approximate 3 month follow-up.
Detailed Description
The eHealth system developed in the present study is dedicated to multimorbid patients' follow-up. The medical device consists in Telemonitoring, Telenotification and Telecoaching. It aims to both increase patient autonomy, with regard to management of his/her pathologies, and facilitate coordination between health professionals. By providing patients with tools enabling early detection of clinical worsening combined with an appropriate management, the medium and long-term objectives are to reduce hospitalizations and improve health status and quality of life of these patients at home. In the first instance, the only objective of the present study is to evaluate the performance and feasibility of implementation of the device. This evaluation is based on a comparison between the telenotifications generated by the software and those calculated from the raw data captured by the software.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Diseases
Keywords
chronic heart failure, chronic obstructive pulmonary disease, diabetes

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
medical device intervention
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
medical device intervention
Other Intervention Name(s)
Nomhad Mobile - Nomhad Chronic
Primary Outcome Measure Information:
Title
Sensitivity and specificity of the tele-notifications
Time Frame
through study completion, an average of 11 months
Secondary Outcome Measure Information:
Title
Sensitivity and specificity of the STABILITY SYSTEM INDICATORS
Time Frame
through study completion, an average of 11 months
Title
Specific self-administered questionnaires about Ease of Use/Usefulness/Satisfaction for each category of user
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients regarding transmission of measured parameters
Description
Mean number of transmission of measured parameters: real versus theoretical.
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: mean number of participation in virtual classroom session
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: mean duration of participation in virtual classroom session
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: mean number of consultations of modules providing medical information
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: cumulative time spent on consultations of modules providing medical information
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: mean duration of phone contacts by type (planned, for notification management, incoming)
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: mean number of phone contacts by type (planned, for notification management, incoming)
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by patients: comparison of real planned phone contacts versus theoretical
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by physicians: mean number of connections
Time Frame
through study completion, an average of 11 months
Title
Acceptability of the system by physicians: mean duration of connections
Time Frame
through study completion, an average of 11 months
Title
Feasibility of the intervention for patients
Description
number of screening failure and prematurely withdrawal
Time Frame
through study completion, an average of 11 months
Title
Feasibility of the intervention for technicians
Description
duration of intervention
Time Frame
through study completion, an average of 11 months
Title
Feasibility of the intervention for nurses
Description
response time following a notification
Time Frame
through study completion, an average of 11 months
Title
Technological performance indices of the system: failures in data transmission
Time Frame
through study completion, an average of 11 months
Title
Technological performance indices of the system: inaccessibility
Time Frame
through study completion, an average of 11 months
Title
Technological performance indices of the system: devices deficiencies
Description
technical problems with any medical devices (leading or not to replacement).
Time Frame
through study completion, an average of 11 months
Title
Number of tele-notification per patient
Time Frame
through study completion, an average of 11 months
Title
Frequency of tele-notifications per patient
Time Frame
through study completion, an average of 11 months
Title
Patient care plan: number of changes implemented by investigators.
Time Frame
through study completion, an average of 11 months
Title
Clinical events including medical consultations, hospitalizations and adverse events
Description
Overall description of medical consultations, hospitalizations and adverse events. For adverse events, in addition, evaluation of seriousness and causal relationship with the medical device of the study.
Time Frame
through study completion, an average of 11 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients presenting all the following characteristics are eligible for inclusion: Adult (>18 yrs), male or female Presenting at least two chronic diseases among the following three: chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes Having been hospitalized in the CHANGE or in any other medical care center (hospital or private clinic) for acute decompensation of CHF or exacerbation of COPD at least once during the 12 months prior to inclusion Able to speak and understand French to a satisfactory standard Having a phone land line Capable of understanding and accepting the study constraints Having signed a written informed consent after a full explanation of the study by the investigator prior to inclusion Exclusion Criteria: Patients presenting any one of the following characteristics are not eligible for inclusion: Pregnant or breast-feeding woman Institutionalized Having a life expectancy of less than 3 months Receiving or having received chemotherapy or radiotherapy for cancer within the past 6 months Undergoing dialysis for chronic renal insufficiency Presenting a condition likely to hamper accomplishment of the study procedures, such as chronic alcoholism, drug or solvent addiction, uncontrolled psychiatric disease or severe cognitive deficiency Not covered by French Social Security Participating or having participated in another interventional trial within the past 30 days
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stephane SH Hominal, doctor
Organizational Affiliation
Centre hospitalier d'Annecy Genevois
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cabinet Privé de Cardiologie - 2, rue jean jaurès
City
Annecy
ZIP/Postal Code
74000
Country
France
Facility Name
Cabinet Privé de Pneumologie - 7 rue gabriel de mortillet
City
Annecy
ZIP/Postal Code
74000
Country
France
Facility Name
Centre Hospitalier d'Annecy Genevois - service cardiologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy
City
PRINGY Cedex
ZIP/Postal Code
74374
Country
France
Facility Name
Centre Hospitalier d'Annecy Genevois - service pneumologie - 1 avenue de l'Hôpital BP 90074 Metz-Tessy
City
Pringy cedex
ZIP/Postal Code
74374
Country
France
Facility Name
Cabinet privé de pneumologie - 28 avenue de Genève
City
Saint Julien en Genevois
ZIP/Postal Code
74160
Country
France
Facility Name
cabinet privé de médecine générale - 18, rue Louis Haase
City
Thones
ZIP/Postal Code
74230
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
14990395
Citation
Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 Jun 15;169(12):1298-303. doi: 10.1164/rccm.200310-1443OC. Epub 2004 Feb 27.
Results Reference
background
PubMed Identifier
18340214
Citation
Conway G. Case management for heart failure in the emergency department. Crit Pathw Cardiol. 2006 Mar;5(1):25-8. doi: 10.1097/01.hpc.0000202240.99184.81.
Results Reference
background
PubMed Identifier
24739471
Citation
Elbert NJ, van Os-Medendorp H, van Renselaar W, Ekeland AG, Hakkaart-van Roijen L, Raat H, Nijsten TE, Pasmans SG. Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-analyses. J Med Internet Res. 2014 Apr 16;16(4):e110. doi: 10.2196/jmir.2790.
Results Reference
background
PubMed Identifier
24250826
Citation
Marcolino MS, Maia JX, Alkmim MB, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013 Nov 8;8(11):e79246. doi: 10.1371/journal.pone.0079246. eCollection 2013.
Results Reference
background
PubMed Identifier
25464906
Citation
Lundell S, Holmner A, Rehn B, Nyberg A, Wadell K. Telehealthcare in COPD: a systematic review and meta-analysis on physical outcomes and dyspnea. Respir Med. 2015 Jan;109(1):11-26. doi: 10.1016/j.rmed.2014.10.008. Epub 2014 Oct 27.
Results Reference
background
PubMed Identifier
24472009
Citation
Cruz J, Brooks D, Marques A. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract. 2014 Mar;68(3):369-78. doi: 10.1111/ijcp.12345. Epub 2014 Jan 28.
Results Reference
background
PubMed Identifier
24798834
Citation
Goldstein RS, O'Hoski S. Telemedicine in COPD: time to pause. Chest. 2014 May;145(5):945-949. doi: 10.1378/chest.13-1656.
Results Reference
background
PubMed Identifier
24163297
Citation
Conway A, Inglis SC, Chang AM, Horton-Breshears M, Cleland JG, Clark RA. Not all systematic reviews are systematic: a meta-review of the quality of systematic reviews for non-invasive remote monitoring in heart failure. J Telemed Telecare. 2013 Sep;19(6):326-37. doi: 10.1177/1357633X13503427. Epub 2013 Sep 25.
Results Reference
background
PubMed Identifier
24352899
Citation
Nakamura N, Koga T, Iseki H. A meta-analysis of remote patient monitoring for chronic heart failure patients. J Telemed Telecare. 2014 Jan;20(1):11-7. doi: 10.1177/1357633X13517352. Epub 2013 Dec 18.
Results Reference
background
PubMed Identifier
24606887
Citation
Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Fam Pract. 2014 Mar 7;15:43. doi: 10.1186/1471-2296-15-43.
Results Reference
background
PubMed Identifier
25768664
Citation
Kitsiou S, Pare G, Jaana M. Effects of home telemonitoring interventions on patients with chronic heart failure: an overview of systematic reviews. J Med Internet Res. 2015 Mar 12;17(3):e63. doi: 10.2196/jmir.4174.
Results Reference
background
PubMed Identifier
25714962
Citation
Kotb A, Cameron C, Hsieh S, Wells G. Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis. PLoS One. 2015 Feb 25;10(2):e0118681. doi: 10.1371/journal.pone.0118681. eCollection 2015.
Results Reference
background
PubMed Identifier
23680885
Citation
Pandor A, Gomersall T, Stevens JW, Wang J, Al-Mohammad A, Bakhai A, Cleland JG, Cowie MR, Wong R. Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis. Heart. 2013 Dec;99(23):1717-26. doi: 10.1136/heartjnl-2013-303811. Epub 2013 May 16.
Results Reference
background
PubMed Identifier
24862840
Citation
Feltner C, Jones CD, Cene CW, Zheng ZJ, Sueta CA, Coker-Schwimmer EJ, Arvanitis M, Lohr KN, Middleton JC, Jonas DE. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2014 Jun 3;160(11):774-84. doi: 10.7326/M14-0083.
Results Reference
background
PubMed Identifier
23880072
Citation
Kitsiou S, Pare G, Jaana M. Systematic reviews and meta-analyses of home telemonitoring interventions for patients with chronic diseases: a critical assessment of their methodological quality. J Med Internet Res. 2013 Jul 23;15(7):e150. doi: 10.2196/jmir.2770. Erratum In: J Med Internet Res. 2013;15(11):e253.
Results Reference
background
PubMed Identifier
20884286
Citation
Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform. 2010 Nov;79(11):736-71. doi: 10.1016/j.ijmedinf.2010.08.006.
Results Reference
background
PubMed Identifier
22104370
Citation
Ekeland AG, Bowes A, Flottorp S. Methodologies for assessing telemedicine: a systematic review of reviews. Int J Med Inform. 2012 Jan;81(1):1-11. doi: 10.1016/j.ijmedinf.2011.10.009. Epub 2011 Nov 21.
Results Reference
background
PubMed Identifier
24731212
Citation
Conway A, Inglis SC, Clark RA. Effective technologies for noninvasive remote monitoring in heart failure. Telemed J E Health. 2014 Jun;20(6):531-8. doi: 10.1089/tmj.2013.0267. Epub 2014 Apr 14.
Results Reference
background
PubMed Identifier
22579043
Citation
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43. doi: 10.1016/S0140-6736(12)60240-2. Epub 2012 May 10.
Results Reference
background
PubMed Identifier
25444838
Citation
Lefevre T, d'Ivernois JF, De Andrade V, Crozet C, Lombrail P, Gagnayre R. What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization. Rev Epidemiol Sante Publique. 2014 Oct;62(5):305-14. doi: 10.1016/j.respe.2014.09.002. Epub 2014 Oct 25.
Results Reference
background
PubMed Identifier
22945950
Citation
Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T. Managing patients with multimorbidity: systematic review of interventions in primary care and community settings. BMJ. 2012 Sep 3;345:e5205. doi: 10.1136/bmj.e5205.
Results Reference
background
PubMed Identifier
23256171
Citation
Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, Leff B, Kent DM, Schunemann HJ; ATS/ERS Ad Hoc Committee on Integrating and Coordinating Efforts in COPD Guideline Development. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012 Dec;9(5):274-81. doi: 10.1513/pats.201208-063ST.
Results Reference
background
PubMed Identifier
25797840
Citation
Onder G, Palmer K, Navickas R, Jureviciene E, Mammarella F, Strandzheva M, Mannucci P, Pecorelli S, Marengoni A; Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS). Eur J Intern Med. 2015 Apr;26(3):157-9. doi: 10.1016/j.ejim.2015.02.020. Epub 2015 Mar 18.
Results Reference
background
PubMed Identifier
23537332
Citation
Martin-Lesende I, Orruno E, Bilbao A, Vergara I, Cairo MC, Bayon JC, Reviriego E, Romo MI, Larranaga J, Asua J, Abad R, Recalde E. Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial). BMC Health Serv Res. 2013 Mar 28;13:118. doi: 10.1186/1472-6963-13-118.
Results Reference
background
PubMed Identifier
19747197
Citation
Sutherland D, Hayter M. Structured review: evaluating the effectiveness of nurse case managers in improving health outcomes in three major chronic diseases. J Clin Nurs. 2009 Nov;18(21):2978-92. doi: 10.1111/j.1365-2702.2009.02900.x. Epub 2009 Sep 11.
Results Reference
background
PubMed Identifier
24617755
Citation
Chow SK, Wong FK. A randomized controlled trial of a nurse-led case management programme for hospital-discharged older adults with co-morbidities. J Adv Nurs. 2014 Oct;70(10):2257-71. doi: 10.1111/jan.12375. Epub 2014 Mar 12.
Results Reference
background
Citation
Prochaska JO, DiClemente CC. Transtheorical therapy toward a more integrative model of change. Psychotherapy: Theory, Research and Practice, 1982;19(3):276-287
Results Reference
background
Links:
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-07/annexes_vf_2013-07-18_14-49-4_836.pdf
Description
Haute Autorité de Santé. Rapport d'évaluation efficience de la télémédecine. Élaboration de matrices d'impacts des effets attendus de la télémédecine: applications aux chantiers prioritaires, juillet 2013.
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/guide_parcours_de_soins_ic_web.pdf
Description
Haute Autorité de Santé. Guide de parcours de soins. Insuffisance cardiaque, juin 2014.
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-04/guide_parcours_de_soins_bpco_finale.pdf
Description
Haute Autorité de Santé. Guide du parcours de soins. Diabète de type 2 de l'adulte, mars 2014.
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/ald8_guidemedecin_diabetetype1_revunp_vucd.pdf
Description
Haute Autorité de Santé. Guide - Affections de longue durée. Diabète de type 1 de l'adulte, juillet 2007.
URL
https://www.google.fr/search?q=4%2BPRADO_Bilan%2Bet%2Bperspectives_SSR_UGECAM_20150312%2BVDEF-2&ie=utf-8&gws_rd=cr&ei=_YNLVeLQPIr4UOiRgJgD
Description
Caisse Nationale d'Assurance Maladie. Programme d'Accompagnement du Retour à Domicile (PRADO). Bilan et perspectives pour les Soins de Suite et de Réadaptation. Prise en charge ambulatoire, 12 mars 2015.
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-07/efficience_tlm_vf_2013-07-18_14-48-38_743.pdf
Description
Haute autorité de santé. Rapport d'évaluation médico-économique. Efficience de la télémédecine: état des lieux de la littérature internationale et cadre d'évaluation, juillet 2013
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-07/guide_grille_de_pilotage_et_de_securite_d_un_projet_de_telemedecine_2013-07-18_13-34-47_545.pdf
Description
Haute autorité de santé. Evaluation et amélioration des pratiques. Grille de pilotage et de sécurité d'un projet de télémédecine, juin 2013.
URL
http://www.has-sante.fr/portail/upload/docs/application/pdf/2014-06/exacerbations_bpco.pdf
Description
Haute Autorité de Santé. Comment prévenir les ré-hospitalisations après une exacerbation de bronchopneumopathie chronique obstructive? Mai 2014.

Learn more about this trial

Evaluation of the Performance of an e-Health System

We'll reach out to this number within 24 hrs